NCT05898763 : Clinical Trial Detail - Cancer Knowledgebase (CKB)

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

NCT ID	NCT05898763
Title	TEIPP Immunotherapy in Patients With NSCLC
Acronym	TEIPP
Recruitment	Completed
Gender	both
Phase	Phase Ib/II
Variant Requirements	No
Sponsors	Erasmus Medical Center
Indications	lung non-small cell carcinoma
Therapies	Pembrolizumab + TEIPP24 TEIPP24
Age Groups:	senior \| adult
Covered Countries	NLD

Facility	Status	City	State	Zip	Country	Details
Leiden University Medical Center		Leiden	South Holland	2333ZA	Netherlands	Details
Erasmus Medical Center		Rotterdam	South Holland	3000 CA	Netherlands	Details

*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field

NCT05898763Clinical Trial Detail